Easton Capital Investment Group::Seth J Orlow, MD, PhD





Partners John H. Friedman Francisco A. Garcia Charles B. Hughes III Edward J. Meyer Richard P. Schneider Venture Partner Seth J Orlow, MD, PhD Mark D. Chen Principal Daniel B. Googel Vice President Milena Adamian, MD, PhD Anup Arora Advisors Lawrence M. Kauvar, PhD Janice L. Gabrilove, MD Roman Perez-Soler, MD Hans Mueller, Ph.D. Harry Kopelman, MD	Seth J Orlow, MD, PhD Venture Partner orlow@eastoncapital.com
		Seth has a longstanding interest in biotechnology and more than 15 years of experience as a consultant to major pharmaceutical companies, biotechnology companies, OTC manufacturers, and private equity firms on early and late stage pre-clinical drug discovery, clinical development, market opportunities, in- and out-licensing and strategy. Seth was a founder of the Anaderm Research Corporation, a privately held drug discovery company acquired by Pfizer in 2002. He is a co-founder of Ivrea Pharmaceuticals, an Easton portfolio company. He is an inventor or co-inventor on numerous patent applications relating to drug discovery and medicinal chemistry. Seth is Chairman of Dermatology and a Professor of Cell Biology, Dermatology & Pediatrics at New York University School of Medicine, New York. He holds an A.B. in Biochemical Sciences from Harvard College and an M.D.-Ph.D. from Albert Einstein College of Medicine in Molecular Pharmacology. Seth currently serves on the Boards of Protez Pharmaceuticals and Transave, Inc.